- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Brenton Fargnoli Explains How Quality Measurement Benchmarks Drive Action
Brenton Fargnoli, MD, medical director of value-based care and director of product marketing and strategy at Flatiron Health, recognizes the importance of benchmarking to further improvement.
Brenton Fargnoli, MD, medical director of value-based care and director of product marketing and strategy at Flatiron Health, recognizes the importance of benchmarking to further improvement.
Transcript
What is the importance of providing practices with a benchmark to understand deficiencies and best practices compared with other practices that work with Flatiron Health?
So benchmarking is key to quality measurements. So measuring quality and getting 85% on a specific quality measure, for example, doesn’t do a whole lot in understanding how that is in relative terms. That’s what where benchmarking comes in. So as a clinician you want to know, "how does my quality score compare to other physicians at my practice? What does this score mean at a national level?" Essentially, "where should I be spending my time for my quality improvement efforts?"
So quality measurement is nice but it’s really taking that measurement and comparing that to benchmarks across your practice across the national network that will ultimately drive action.
New Insights on Breast Cancer Outcomes Among Sexual, Gender Minorities
December 7th 2023Despite there being a great demand for data collection on sexual orientation and gender identity in the cancer space, individuals who identify as a sexual and gender minority remain poorly represented.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Exagamglogene Autotemcel Meets End Points in Severe Sickle Cell Disease, β-Thalassemia
December 7th 2023Two posters set to be presented at the 65th American Society of Hematology Annual Meeting & Exposition met their primary and secondary end points regarding exagamglogene autotemcel therapy for sickle cell disease and β-thalassemia.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Race/Ethnicity May Influence Local Recurrence in DCIS, Adjuvant Treatment
December 6th 2023Disparities in 10-year local recurrence following breast-conserving surgery were seen among women with ductal carcinoma in situ (DCIS) treated over a nearly 4-decade span at Memorial Sloan Kettering Cancer Center, with Black women having the highest rate.
Read More
SDOH in Cancer Care Highlight Multifactorial Equity Issues
December 6th 2023A trio of speakers addressed the importance of social determinants of health (SDOH) in cancer care on day 1 of the 46th annual San Antonio Breast Cancer Symposium in the session, “Social Determinants of Health: Impact on Cancer Care.”
Read More
